AAAAAA
Results:
1-10
|
Results: 10
Authors:
Ericsson, H
Schwieler, J
Lindmark, B
Lofdahl, P
Thulin, T
Regardh, CG
Citation: H. Ericsson et al., Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients, CHIRALITY, 13(3), 2001, pp. 130-134
Authors:
Neuhoff, S
Langguth, P
Dressler, C
Andersson, TB
Regardh, CG
Spahn-Langguth, H
Citation: S. Neuhoff et al., Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites, INT J CL PH, 38(4), 2000, pp. 168-179
Authors:
Hilgendorf, C
Spahn-Langguth, H
Regardh, CG
Lipka, E
Amidon, GL
Langguth, P
Citation: C. Hilgendorf et al., Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport, J PHARM SCI, 89(1), 2000, pp. 63-75
Authors:
Ericsson, H
Bredberg, U
Eriksson, U
Jolin-Mellgard, A
Nordlander, M
Regardh, CG
Citation: H. Ericsson et al., Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers, ANESTHESIOL, 92(4), 2000, pp. 993-1001
Authors:
Ericsson, H
Tholander, B
Regardh, CG
Citation: H. Ericsson et al., In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animalspecies and man, EUR J PH SC, 8(1), 1999, pp. 29-37
Authors:
Ericsson, H
Fakt, C
Jolin-Mellgard, A
Nordlander, M
Sohtell, L
Sunzel, M
Regardh, CG
Citation: H. Ericsson et al., Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers, BR J CL PH, 47(5), 1999, pp. 531-538
Authors:
Ericsson, H
Tholander, B
Bjorkman, JA
Nordlander, M
Regardh, CG
Citation: H. Ericsson et al., Pharmacokinetics of new calcium channel antagonist clevidipine in the rat,rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs, DRUG META D, 27(5), 1999, pp. 558-564
Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteersafter intravenous infusion
Authors:
Ericsson, H
Fakt, C
Hoglund, L
Jolin-Mellgard, A
Nordlander, M
Sunzel, M
Regardh, CG
Citation: H. Ericsson et al., Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteersafter intravenous infusion, EUR J CL PH, 55(1), 1999, pp. 61-67
Authors:
Doppenschmitt, S
Langguth, P
Regardh, CG
Andersson, TB
Hilgendorf, C
Spahn-Langguth, H
Citation: S. Doppenschmitt et al., Characterization of binding properties to human P-glycoprotein: Development of a [H-3]verapamil radioligand-binding assay, J PHARM EXP, 288(1), 1999, pp. 348-357
Authors:
Doppenschmitt, S
Spahn-Langguth, H
Regardh, CG
Langguth, P
Citation: S. Doppenschmitt et al., Role of P-glycoprotein-mediated secretion in absorptive drug permeability:An approach using passive membrane permeability and affinity to P-glycoprotein, J PHARM SCI, 88(10), 1999, pp. 1067-1072
Risultati:
1-10
|